skip to primary navigationskip to content
 

MRC Cancer Unit to participate in the European Project Evomet, which will train future leaders in metastasis research

last modified Sep 04, 2020 03:07 PM

 

sv sm

  • The goal is to train 15 young researchers in the understanding of metastatic processes and their evolution, with the aim to identify therapeutic solutions.
  • The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe.
  • Awarded in the Innovative Training Networks Marie Skłodowska-Curie Actions call of the European Commission, the Evomet project has received €4 M and will last for four years.

The prevalence of cancer is increasing, with more than 3.5 million people affected in Europe, metastasis being responsible for the vast majority of deaths related to this disease. The European Evomet project, coordinated by IRB Barcelona, seeks to train future metastasis researchers to apply the knowledge generated in basic research to the search for therapeutic solutions. The objective is to leverage the development of drugs and, ultimately, have an impact on the clinical treatment given to these patients, who have the worst prognosis. Dr Sakari Vanharanta, Programme Leader at the MRC Cancer Unit, will be leading the Evomet project at the University of Cambridge.